{"id":"NCT02224157","sponsor":"AstraZeneca","briefTitle":"A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma","officialTitle":"A Clinical Study Comparing Symbicort 'as Needed' With Pulmicort Twice Daily Plus Terbutaline 'as Needed' in Adult and Adolescent Patients With Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-11-28","primaryCompletion":"2017-08-16","completion":"2017-08-16","firstPosted":"2014-08-25","resultsPosted":"2019-11-25","lastUpdate":"2019-11-25"},"enrollment":4215,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"budesonide/formoterol 'as needed' + budesonide placebo bid","otherNames":[]},{"type":"DRUG","name":"budesonode bid + terbutaline 'as needed'","otherNames":[]}],"arms":[{"label":"Symbicort \"as needed\"+placebo Pulmicort bid","type":"EXPERIMENTAL"},{"label":"Pulmicort bid + terbutaline \"as needed\"","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to test if Symbicort (budesonide/formoterol) Turbuhaler is effective in treating asthma when used 'as needed' in patients with milder asthma. The efficacy of Symbicort 'as needed' will be compared with Pulmicort (budesonide) Turbuhaler twice daily plus terbutaline Turbuhaler 'as needed'","primaryOutcome":{"measure":"Annual Severe Asthma Exacerbation Rate - Non-inferiority Analysis","timeFrame":"up to 52 weeks","effectByArm":[{"arm":"Placebo Bid + Symbicort 'as Needed' (Experimental)","deltaMin":0.11,"sd":null},{"arm":"Pulmicort Bid + Terbutaline 'as Needed' (Active Comparator)","deltaMin":0.12,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":340,"countries":["Australia","Brazil","Bulgaria","Chile","Colombia","Czechia","France","Germany","Hungary","Mexico","New Zealand","Peru","Philippines","Poland","Romania","Russia","Saudi Arabia","Slovakia","South Africa","South Korea","Spain","Sweden","Thailand","Ukraine","Vietnam"]},"refs":{"pmids":["33548020","29768147","28069068","27912982"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=2649&filename=d589sc00003-revised-csp-edition-4_12Oct2016_Redacted_pdfa.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=2649&filename=D589SC00003-statistical-analysis-plan-edition-2_06SEP2017_pdfa.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":66,"n":2089},"commonTop":["Viral upper respiratory tract infection","Upper respiratory tract infection","Asthma","Bronchitis","Pharyngitis"]}}